HARVARD BIOSCIENCE INC (HBIO) › Shareholders' EquityHARVARD BIOSCIENCE INC (HBIO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $66.72M2009: $75.26M2010: $90.25M2011: $95.50M2012: $104.21M2013: $94.48M2014: $95.47M2015: $77.60M2016: $72.20M2017: $80.90M2018: $82.72M2019: $81.69M2020: $76.68M2021: $83.40M2022: $72.22M2023: $73.07M2024: $63.34M2025: $13.73M$13.73M2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$13.73M-78.3%2024$63.34M-13.3%2023$73.07M+1.2%2022$72.22M-13.4%2021$83.40M+8.8%2020$76.68M-6.1%2019$81.69M-1.2%2018$82.72M+2.3%2017$80.90M+12.1%2016$72.20M-7.0%2015$77.60M-18.7%2014$95.47M+1.0%2013$94.48M-9.3%2012$104.21M+9.1%2011$95.50M+5.8%2010$90.25M+19.9%2009$75.26M+12.8%2008$66.72M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share